These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]
10. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible? Marasini N; Kaminskas LM Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591 [TBL] [Abstract][Full Text] [Related]
12. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles. Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573 [TBL] [Abstract][Full Text] [Related]
13. Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents. Umemoto S; Nakahashi-Ouchida R; Yuki Y; Kurokawa S; Machita T; Uchida Y; Mori H; Yamanoue T; Shibata T; Sawada SI; Ishige K; Hirano T; Fujihashi K; Akiyoshi K; Kurashima Y; Tokuhara D; Ernst PB; Suzuki M; Kiyono H NPJ Vaccines; 2023 Jul; 8(1):106. PubMed ID: 37488116 [TBL] [Abstract][Full Text] [Related]
14. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. Li M; Zhao M; Fu Y; Li Y; Gong T; Zhang Z; Sun X J Control Release; 2016 Apr; 228():9-19. PubMed ID: 26941035 [TBL] [Abstract][Full Text] [Related]
15. Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine. Okada K; Yamasoba T; Kiyono H Adv Otorhinolaryngol; 2011; 72():31-6. PubMed ID: 21865684 [TBL] [Abstract][Full Text] [Related]
16. The mucosal immune system for vaccine development. Lamichhane A; Azegamia T; Kiyonoa H Vaccine; 2014 Nov; 32(49):6711-23. PubMed ID: 25454857 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for nasal vaccination. Csaba N; Garcia-Fuentes M; Alonso MJ Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350 [TBL] [Abstract][Full Text] [Related]
18. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity. Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Hodge LM; Marinaro M; Jones HP; McGhee JR; Kiyono H; Simecka JW Infect Immun; 2001 Apr; 69(4):2328-38. PubMed ID: 11254590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]